Results 41 to 50 of about 22,116 (224)

Clinical Outcomes and Patient Experiences With Celiprolol Therapy in Vascular Ehlers–Danlos Syndrome: The First Non‐European Cohort

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Vascular Ehlers–Danlos syndrome (vEDS) is a hereditary connective tissue disorder caused by heterozygous pathogenic variants in COL3A1. European studies have shown that celiprolol may reduce the risk of life‐threatening vascular events, but outcomes in non‐European populations and the therapy's psychological impact remain unclear. We conducted
Megumi Furuhata‐Yoshimura   +2 more
wiley   +1 more source

Spontaneous perforated pyometra presenting as an acute abdomen: appraisal of three consecutive cases

open access: yesJournal of Society of Surgeons of Nepal, 2018
Introduction: Pyometra is the accumulation of purulent fluid in the uterine cavity caused by impaired drainage of pus due to benign or malignant conditions; rarely with resultant spontaneous uterine perforation brought about by uterine distension ...
Pooja Paudyal   +5 more
doaj   +1 more source

Outcomes from blind versus ultrasound-guided uterine evacuation: A retrospective cohort analysis. [PDF]

open access: yesActa Obstet Gynecol Scand
There were low complication rates for blind and ultrasound‐guided uterine evacuations. However, ultrasound guidance was utilized for higher risk cases and significantly reduced the volume of retained tissue in complicated cases. The use of ultrasound guidance by doctors and sonographers for uterine evacuation is a compelling choice where available ...
Dowthwaite S   +4 more
europepmc   +2 more sources

Safe abortion – Still a neglected scenario: A study of septic abortions in a tertiary hospital of Rural India [PDF]

open access: yes, 2010
Background and Aims: In spite abortion has been legalized in India over three decades, unsafe abortion continues to be a significant contributor of maternal mortality and morbidity.
Bhattacharya, S   +3 more
core   +1 more source

A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study [PDF]

open access: yes, 2015
PURPOSE: Cediranib is a multi-tyrosine kinase inhibitor targeting vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF) receptors.
Bender, David   +13 more
core   +1 more source

Spontaneous hemoperitoneum in a 29‐week pregnancy with a history of endometriosis: A case report and review of the literature

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 31-37, April 2025.
Abstract Spontaneous hemoperitoneum in pregnancy (SHIP) is defined as sudden, nontraumatic intraperitoneal bleeding that occurs during pregnancy or up to 42 days postpartum. The incidence ranges between 4 and 4.9 per 100 000 births. Although seen rarely, it is associated with perinatal morbidity and mortality due to maternal hemodynamic instability ...
Shamsi Mehdiyev   +3 more
wiley   +1 more source

Uterine Rupture in Early Pregnancy [PDF]

open access: yes, 2017
info:eu-repo/semantics ...
Cardoso, Luísa   +4 more
core   +1 more source

Endometrial biopsy with uretral plastic No. 12 sonde [PDF]

open access: yes, 1995
The authors demonstrate technique for obtaining endometrial fragments in 25 patients sent to Gynecological Cancer Preventive Service of the Arnaldo Vieira de Carvalho Cancer Institute, during the period of September 1991 through January 1992, presenting ...
Baracat, Fausto Farah   +2 more
core   +1 more source

Intraoperative color Doppler during manual vacuum aspiration prevents retained products of conception

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To investigate whether intraoperative confirmation of the disappearance of uterine cavity blood flow using color Doppler during manual vacuum aspiration (MVA) for missed miscarriage reduces the occurrence of retained products of conception (RPOC). Methods We conducted a retrospective cohort study of 202 patients who underwent MVA for
Tatsuya Yoshihara   +6 more
wiley   +1 more source

Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus. [PDF]

open access: yes, 2014
BackgroundBevacizumab and temsirolimus are active agents in gynecologic tumors. Temsirolimus attenuates upregulation of HIF-1α levels, a resistance mechanism for antiangiogenics, and targets the PI3-kinase/AKT/mTOR axis, commonly aberrant in these tumors.
Falchook, Gerald S   +9 more
core   +7 more sources

Home - About - Disclaimer - Privacy